BRUNO, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 5.875
EU - Europa 4.129
AS - Asia 2.691
SA - Sud America 104
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 8
Totale 12.834
Nazione #
US - Stati Uniti d'America 5.828
CN - Cina 2.182
IE - Irlanda 1.297
IT - Italia 668
UA - Ucraina 569
FI - Finlandia 477
DE - Germania 440
SG - Singapore 392
SE - Svezia 257
GB - Regno Unito 159
FR - Francia 93
BR - Brasile 91
BE - Belgio 46
CA - Canada 39
IN - India 33
NL - Olanda 27
CZ - Repubblica Ceca 22
JP - Giappone 20
AU - Australia 13
IR - Iran 13
AT - Austria 12
TR - Turchia 12
CH - Svizzera 11
EU - Europa 10
RU - Federazione Russa 10
RO - Romania 8
HK - Hong Kong 6
MU - Mauritius 6
AR - Argentina 5
IL - Israele 4
LT - Lituania 4
LV - Lettonia 4
MX - Messico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
JO - Giordania 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MD - Moldavia 3
PT - Portogallo 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BG - Bulgaria 2
EC - Ecuador 2
ES - Italia 2
HU - Ungheria 2
IQ - Iraq 2
MA - Marocco 2
PA - Panama 2
PL - Polonia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
ID - Indonesia 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
VN - Vietnam 1
Totale 12.834
Città #
Dublin 1.293
Chandler 1.254
Jacksonville 722
Nanjing 602
Boardman 439
Ashburn 402
Princeton 268
Singapore 241
Lawrence 235
Nanchang 235
Wilmington 219
Helsinki 202
Shenyang 189
Beijing 178
Hebei 177
Milan 176
Medford 166
Changsha 160
Ann Arbor 137
Jiaxing 128
Shanghai 118
New York 105
Pavia 100
Tianjin 86
Hangzhou 82
Seattle 61
Woodbridge 55
Los Angeles 49
Norwalk 46
Brussels 44
Verona 39
Falkenstein 38
Fairfield 31
Houston 28
Pune 28
Toronto 28
Munich 24
Washington 24
Nuremberg 22
Dallas 19
Ningbo 18
Tokyo 18
Brno 17
Kunming 17
San Francisco 16
London 15
Turin 15
Zhengzhou 15
Des Moines 14
Frankfurt am Main 14
Piscataway 13
Rome 13
Auburn Hills 11
Chicago 11
Guangzhou 11
Jinan 11
Vicenza 11
Paris 8
Redwood City 8
Taizhou 8
Tappahannock 8
Berlin 7
Brescia 7
Dearborn 7
Orange 7
São Paulo 7
Corsico 6
Varese 6
Vigevano 6
Zurich 6
Alessandria 5
Bergamo 5
Caccamo 5
Falls Church 5
Fuzhou 5
Melbourne 5
Naples 5
Rozzano 5
Bologna 4
Brasília 4
Buccinasco 4
Buenos Aires 4
Canberra 4
Cinisello Balsamo 4
Como 4
Curitiba 4
Desio 4
Florence 4
Haikou 4
Lanzhou 4
Motta Visconti 4
Newark 4
Olomouc 4
Ottawa 4
Parma 4
Riga 4
Rio de Janeiro 4
Sacramento 4
Santa Clara 4
Seregno 4
Totale 8.909
Nome #
Hepatitis B virus genotype distribution in HIV-1 coinfected patients 228
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 185
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 98
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 97
The Pavia consensus statement 92
Host factors affecting the outcome of treatment of hepatitis C 86
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 83
Mice and rabbits: Animal models for HIV-1 infection 83
Challenges for hepatitis C patients coinfected with HIV. 82
Aggressive daily interferon therapy in HIV-HCV coinfected patients 79
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 77
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. 75
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 75
Management of hepatitis C in human immunodeficiency virus-infected patients 71
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 70
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 70
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 70
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 68
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 68
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 68
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT 68
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 68
Will direct-acting antivirals make a difference in HIV-HCV coinfected patients? 68
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 67
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a 67
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts. 67
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 67
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 67
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 66
Hepatotoxicity and nelfinavir: a meta-analysis 66
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 66
Malattie Infettive 66
Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C 66
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 66
Reply about: Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis 65
Treatment of echinococcal abdominal cysts 65
Ultrasound in the diagnosis of gallbladder ascariasis 64
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. 64
Transfusion-transmitted virus infection in HIV-1-seropositive patients 64
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 64
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 64
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas. 63
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 62
Clinical management of hepatic abscesses in HIV patients 62
The role of the rs12979860 polymorphism of the interleukin-28b as a predictor of sustained virological response after antiviral therapy in patients with hemophilia and chronic hepatitis C 62
Portal Hypertension in Childhood Bilateral Wilms' Tumor Survivor: An Excellent Indication for TIPS 62
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 62
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. 61
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 60
Malattie Infettive 60
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 60
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 60
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 60
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 59
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. 59
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 59
The Management of Hepatitis B/HIV1 coinfected patients starting their first HAART regimen Treating two infections for the price of one drug?. 59
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 59
Effect of the IL-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in HIV co-infected patients 59
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 59
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 59
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 58
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 58
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 58
Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. 57
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 57
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 56
YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient. 56
Prophylaxis and treatment of hepatitis B in immunocompromised patients 56
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 56
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 56
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 56
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. 56
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis. 56
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 56
Percutaneous drainage of echinococcal cysts (PAIR--puncture, aspiration, injection, reaspiration): results of a worldwide survey for assessment of its safety and efficacy. WHO-Informal Working Group on Echinococcosis-Pair Network 55
Epatite Cronica C: l'ottimizzazione della terapiaCapitolo:efficacia terapeutica , aderenza alla terapia e riduzione di dose in pazienti con epatite cronica C 55
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 55
Pathogenesis of liver damage in HCV-HIV patients. 55
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 55
Pathogenesis of liver damage in HCV-HIV patients 55
Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV coinfected patients 55
Echinococcal liver cysts: treatment with echo-guided percutaneous puncture PAIR for echinococcal liver cysts 55
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 55
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 55
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 55
Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. 54
Infettivologia e Parassitologia Vol I A-I 54
Is second biopsy helpful in the diagnosis of hepatocellular carcinoma with a first negative biopsy? 54
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 54
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. 54
Antibiotic stewardship and empirical antibiotic treatment: How can they get along? 54
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 54
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 54
High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus 53
Endocardite, pericarditee miocardite 53
Epatiti Virali Acute 53
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin. 53
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 53
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 53
Totale 6.563
Categoria #
all - tutte 69.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020419 0 0 0 0 0 0 0 114 7 203 85 10
2020/20211.222 124 93 81 105 18 149 12 202 77 161 151 49
2021/20221.112 34 14 22 11 28 30 23 73 76 18 151 632
2022/20233.645 386 248 40 286 323 368 7 192 1.541 49 145 60
2023/20241.725 173 271 73 88 222 378 91 130 13 64 74 148
2024/20251.653 111 349 103 179 82 238 472 119 0 0 0 0
Totale 13.305